您当前的位置：
首页 >
文章列表页 >
Mechanism of Qizhu Kang'ai Prescription for Inhibiting Proliferation of Hepatocellular Carcinoma by Regulating Tumor Metabolic Reprogramming via PCK1/Akt/p21 Signal Axis
更新时间：2023-12-28

    • Mechanism of Qizhu Kang'ai Prescription for Inhibiting Proliferation of Hepatocellular Carcinoma by Regulating Tumor Metabolic Reprogramming via PCK1/Akt/p21 Signal Axis

    • “The latest research has found that Qizhu anti-cancer formula can regulate the metabolic reprogramming of liver cancer cells, inhibit cell proliferation, and provide new ideas for liver cancer treatment.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 3, Pages: 26-36(2024)

    • DOI：10.13422/j.cnki.syfjx.20232424    

      CLC： R2-0;R22;R242;R285.5;R735.7

    • Received：21 August 2023，

      Published Online：03 November 2023，

      Published：05 February 2024

    移动端阅览

  • ZHONG Xin,HU Rui,LI Jing,et al.Mechanism of Qizhu Kang'ai Prescription for Inhibiting Proliferation of Hepatocellular Carcinoma by Regulating Tumor Metabolic Reprogramming via PCK1/Akt/p21 Signal Axis[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(03):26-36. DOI： 10.13422/j.cnki.syfjx.20232424.

  •  
  •  

0

Views

55

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mechanism of Qingrun Prescription-containing Serum Improving Insulin Resistance in HepG2 Cells via Branched-chain α-keto Acid Dehydrogenase Regulation of Branched-chain Amino Acids （BCAAs）/mTOR Pathway
Research Progress of Traditional Chinese Medicine Intervention in Malignant Tumor Metastasis Based on Metabolic Reprogramming
Compound Xishu Granules Inhibit Proliferation of Hepatocellular Carcinoma Cells by Regulating Ferroptosis
Mechanism of Treatment of Hepatocellular Carcinoma with Traditional Chinese Medicine Based on Epigenetic Regulation： A Review
Mechanism of Si Junzitang in Inhibiting Hepatocellular Carcinoma Progression Through Regulating O-GlcNAcylation of NF-κB p65 in Paracancerous Tissues

Related Author

BU Xiangwei
HAO Xiaohui
ZHANG Runyun
ZHANG Meizhen
WANG Ze
WANG Haoshuo
WANG Jie
NI Qing

Related Institution

Shunyi Hospital，Beijing TCM Hospital
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine（TCM）
Guang'anmen Hospital，China Academy of Chinese Medicine Sciences
Shenzhen Hospital， Guangzhou University of Chinese Medicine （ Futian ）
Beijing Institute of Traditional Chinese Medicine，Beijing University of Chinese Medicine
0